BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32107550)

  • 1. HDAC3 functions as a positive regulator in Notch signal transduction.
    Ferrante F; Giaimo BD; Bartkuhn M; Zimmermann T; Close V; Mertens D; Nist A; Stiewe T; Meier-Soelch J; Kracht M; Just S; Klöble P; Oswald F; Borggrefe T
    Nucleic Acids Res; 2020 Apr; 48(7):3496-3512. PubMed ID: 32107550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC3 promotes pulmonary fibrosis by activating NOTCH1 and STAT1 signaling and up-regulating inflammasome components AIM2 and ASC.
    Zheng Q; Lei Y; Hui S; Tong M; Liang L
    Cytokine; 2022 May; 153():155842. PubMed ID: 35306425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation of Notch1 represses its target gene expression during cell stress.
    Antila CJM; Rraklli V; Blomster HA; Dahlström KM; Salminen TA; Holmberg J; Sistonen L; Sahlgren C
    Cell Death Differ; 2018 Mar; 25(3):600-615. PubMed ID: 29305585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
    Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
    Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase.
    Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS
    J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics.
    Ferrante F; Giaimo BD; Friedrich T; Sugino T; Mertens D; Kugler S; Gahr BM; Just S; Pan L; Bartkuhn M; Potente M; Oswald F; Borggrefe T
    Cell Death Dis; 2022 Jul; 13(7):600. PubMed ID: 35821235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response.
    Long J; Fang WY; Chang L; Gao WH; Shen Y; Jia MY; Zhang YX; Wang Y; Dou HB; Zhang WJ; Zhu J; Liang AB; Li JM; Hu J
    Leukemia; 2017 Dec; 31(12):2761-2770. PubMed ID: 28462918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response.
    Hein K; Mittler G; Cizelsky W; Kühl M; Ferrante F; Liefke R; Berger IM; Just S; Sträng JE; Kestler HA; Oswald F; Borggrefe T
    Sci Signal; 2015 Mar; 8(369):ra30. PubMed ID: 25805888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.
    Pozzo F; Bittolo T; Arruga F; Bulian P; Macor P; Tissino E; Gizdic B; Rossi FM; Bomben R; Zucchetto A; Benedetti D; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Deaglio S; Gattei V; Dal Bo M
    Leukemia; 2016 Jan; 30(1):182-9. PubMed ID: 26165233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.
    Ahn MY; Chung HY; Choi WS; Lee BM; Yoon S; Kim HS
    Int J Oncol; 2010 Jan; 36(1):125-31. PubMed ID: 19956841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
    Lin W; Zhang Q; Liu L; Yin S; Liu Z; Cao W
    Kidney Int; 2017 Sep; 92(3):669-679. PubMed ID: 28416226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
    Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
    Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 70 (Hsp70) interacts with the Notch1 intracellular domain and contributes to the activity of Notch signaling in myelin-reactive CD4 T cells.
    Juryńczyk M; Lewkowicz P; Domowicz M; Mycko MP; Selmaj KW
    J Neuroimmunol; 2015 Oct; 287():19-26. PubMed ID: 26439956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase USP10 regulates Notch signaling in the endothelium.
    Lim R; Sugino T; Nolte H; Andrade J; Zimmermann B; Shi C; Doddaballapur A; Ong YT; Wilhelm K; Fasse JWD; Ernst A; Kaulich M; Husnjak K; Boettger T; Guenther S; Braun T; Krüger M; Benedito R; Dikic I; Potente M
    Science; 2019 Apr; 364(6436):188-193. PubMed ID: 30975888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.
    Kluk MJ; Ashworth T; Wang H; Knoechel B; Mason EF; Morgan EA; Dorfman D; Pinkus G; Weigert O; Hornick JL; Chirieac LR; Hirsch M; Oh DJ; South AP; Leigh IM; Pourreyron C; Cassidy AJ; Deangelo DJ; Weinstock DM; Krop IE; Dillon D; Brock JE; Lazar AJ; Peto M; Cho RJ; Stoeck A; Haines BB; Sathayanrayanan S; Rodig S; Aster JC
    PLoS One; 2013; 8(6):e67306. PubMed ID: 23825651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia.
    Pinnell N; Yan R; Cho HJ; Keeley T; Murai MJ; Liu Y; Alarcon AS; Qin J; Wang Q; Kuick R; Elenitoba-Johnson KS; Maillard I; Samuelson LC; Cierpicki T; Chiang MY
    Immunity; 2015 Nov; 43(5):870-83. PubMed ID: 26522984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.